Top 3 Health Care Stocks That May Explode In Q4
Top 3 Health Care Stocks That May Explode In Q4
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
醫療保健行業中超賣最多的股票爲買入被低估的公司提供了機會。
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
RSI是一個動量指標，它比較股票在價格上漲的日子裏的走強與價格下跌的日子的走強。與股票的價格走勢相比，它可以讓交易者更好地了解股票在短期內的表現。根據Benzinga Pro的數據，當相對強弱指數低於30時，資產通常被視爲超賣。
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
以下是該行業主要超賣參與者的最新名單，其相對強弱指數接近或低於30。
Silence Therapeutics PLC – ADR (NASDAQ:SLN)
Silence Therapeutics PLC — ADR（納斯達克：SLN）
- On Dec. 10, Chardan Capital analyst Keay Nakae maintained Silence Therapeutics with a Buy and maintained a $55 price target. The company's stock fell around 41% over the past month and has a 52-week low of $5.81.
- RSI Value: 26.72
- SLN Price Action: Shares of Silence Therapeutics fell 3.4% to close at $6.51 on Tuesday.
- Benzinga Pro's real-time newsfeed alerted to latest SLN news.
- 12月10日，Chardan Capital分析師Keay Nakae維持了Silence Therapeutics的買入，並維持了55美元的目標股價。該公司的股票在過去一個月中下跌了約41％，跌至52周低點5.81美元。
- RSI 值：26.72
- SLN價格走勢：Silence Therapeutics的股價週二下跌3.4％，收於6.51美元。
- Benzinga Pro的實時新聞提醒了最新的SLN新聞。
ModivCare Inc (NASDAQ:MODV)
ModivCare Inc（納斯達克股票代碼：MODV）
- On Nov. 6, ModivCare posted weaker-than-expected quarterly results. "This quarter has demonstrated positive momentum, reflected in both operational enhancements and strengthened relationships, even amid shifts in the broader healthcare market. We delivered solid third-quarter results, reporting $43 million of adjusted EBITDA and a 2% increase in consolidated revenue, driven primarily by 5% growth in our personal care services segment," stated L. Heath Sampson, President and CEO. The company's stock fell around 26% over the past five days and has a 52-week low of $11.00.
- RSI Value: 28.52
- MODV Price Action: Shares of ModivCare fell 11.4% to close at $14.10 on Tuesday.
- Benzinga Pro's charting tool helped identify the trend in MODV stock.
- 11月6日，ModivCare公佈的季度業績低於預期。“即使在更廣泛的醫療保健市場發生變化的情況下，本季度也表現出積極的勢頭，這既反映在運營的改善上，也反映在關係的加強上。總裁兼首席執行官L. Heath Sampson表示，我們實現了穩健的第三季度業績，調整後的息稅折舊攤銷前利潤爲4,300萬美元，合併收入增長了2％，這主要是由個人護理服務板塊增長5％的推動的。該公司的股票在過去五天中下跌了約26％，跌至52周低點11.00美元。
- RSI 值：28.52
- MODV價格走勢：週二，ModivCare的股價下跌11.4％，收於14.10美元。
- Benzinga Pro的圖表工具幫助確定了MODV股票的走勢。
Olema Pharmaceuticals Inc (NASDAQ:OLMA)
奧萊瑪製藥公司（納斯達克股票代碼：OLMA）
- On Dec. 10, Olema Oncology presented updated clinical results for Palazestrant in combination with Ribociclib at the San Antonio Breast Cancer Symposium. The company's stock fell around 37% over the past five days and has a 52-week low of $6.08.
- RSI Value: 23.69
- OLMA Price Action: Shares of Olema Pharmaceuticals fell 4.7% to close at $6.14 on Tuesday.
- Benzinga Pro's signals feature notified of a potential breakout in OLMA shares.
- 12月10日，Olema Oncology在聖安東尼奧乳腺癌研討會上公佈了Palazestrant與Ribociclib聯合使用的最新臨床結果。該公司的股票在過去五天中下跌了約37％，跌至52周低點6.08美元。
- RSI 值：23.69
- OLMA價格走勢：週二，奧萊瑪製藥股價下跌4.7％，收於6.14美元。
- Benzinga Pro的信號功能被告知OLMA股票可能出現突破。
Read This Next:
接下來閱讀這篇文章：
- Top 2 Utilities Stocks That Could Sink Your Portfolio This Quarter
- 本季度可能使您的投資組合陷入困境的兩大公用事業股票
